194 related articles for article (PubMed ID: 12469629)
1. [Use of conjugated allergen-polymer vaccines (pollen allergens of new generation) for allergen-specific immunotherapy].
Petrov RV; Khaitov RM; Fedoseeva VI; Nekrasov AV; Il'ina NI
Ter Arkh; 2002; 74(10):37-40. PubMed ID: 12469629
[TBL] [Abstract][Full Text] [Related]
2. Molecular composition and biological activity of commercial birch pollen allergen extracts.
Focke M; Marth K; Valenta R
Eur J Clin Invest; 2009 May; 39(5):429-36. PubMed ID: 19302561
[TBL] [Abstract][Full Text] [Related]
3. [Development of new sensitizations to allergic components in birch pollen extract during specific immunotherapy].
Modrzyński M; Zawisza E
Przegl Lek; 2003; 60(3):130-2. PubMed ID: 14575011
[TBL] [Abstract][Full Text] [Related]
4. The allergen profile of beech and oak pollen.
Egger C; Focke M; Bircher AJ; Scherer K; Mothes-Luksch N; Horak F; Valenta R
Clin Exp Allergy; 2008 Oct; 38(10):1688-96. PubMed ID: 18754759
[TBL] [Abstract][Full Text] [Related]
5. Urticaria is associated with birch-pollen sensitization.
Hesselmar B; Eriksson B; Aberg N
Pediatr Allergy Immunol; 2007 Dec; 18(8):692-5. PubMed ID: 17651384
[TBL] [Abstract][Full Text] [Related]
6. Artemisia and Ambrosia hypersensitivity: co-sensitization or co-recognition?
Asero R; Wopfner N; Gruber P; Gadermaier G; Ferreira F
Clin Exp Allergy; 2006 May; 36(5):658-65. PubMed ID: 16650052
[TBL] [Abstract][Full Text] [Related]
7. Sensitization to different pollens and allergic disease in 4-year-old Swedish children.
Ghunaim N; Wickman M; Almqvist C; Söderström L; Ahlstedt S; van Hage M
Clin Exp Allergy; 2006 Jun; 36(6):722-7. PubMed ID: 16776672
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
[TBL] [Abstract][Full Text] [Related]
9. Injection immunotherapy with different airborne allergens did not prevent de novo sensitization to ragweed and birch pollen north of Milan.
Asero R
Int Arch Allergy Immunol; 2004 Jan; 133(1):49-54. PubMed ID: 14646378
[TBL] [Abstract][Full Text] [Related]
10. Specific immunotherapy with allergoids in atopic subjects, hyporeactive to other vaccines.
Vargiu G; Valcurone G; Agostoni A; Sacchi G; Tassi GC
Boll Ist Sieroter Milan; 1986; 65(3):230-6. PubMed ID: 3778658
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the T cell response to the major hazelnut allergen, Cor a 1.04: evidence for a relevant T cell epitope not cross-reactive with homologous pollen allergens.
Bohle B; Radakovics A; Lüttkopf D; Jahn-Schmid B; Vieths S; Ebner C
Clin Exp Allergy; 2005 Oct; 35(10):1392-9. PubMed ID: 16238801
[TBL] [Abstract][Full Text] [Related]
12. Symptoms to pollen and fruits early in life and allergic disease at 4 years of age.
Mai XM; Neuman A; Ostblom E; Pershagen G; Nordvall L; Almqvist C; van Hage M; Wickman M
Allergy; 2008 Nov; 63(11):1499-504. PubMed ID: 18721247
[TBL] [Abstract][Full Text] [Related]
13. Side-effects of allergen-specific immunotherapy: a prospective multi-centre study.
Winther L; Arnved J; Malling HJ; Nolte H; Mosbech H
Clin Exp Allergy; 2006 Mar; 36(3):254-60. PubMed ID: 16499635
[TBL] [Abstract][Full Text] [Related]
14. Antibody profiles and self-reported symptoms to pollen-related food allergens in grass pollen-allergic patients from northern Europe.
Ghunaim N; Grönlund H; Kronqvist M; Grönneberg R; Söderström L; Ahlstedt S; van Hage-Hamsten M
Allergy; 2005 Feb; 60(2):185-91. PubMed ID: 15647039
[TBL] [Abstract][Full Text] [Related]
15. Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber.
Horak F; Zieglmayer P; Zieglmayer R; Lemell P; Devillier P; Montagut A; Mélac M; Galvain S; Jean-Alphonse S; Van Overtvelt L; Moingeon P; Le Gall M
J Allergy Clin Immunol; 2009 Sep; 124(3):471-7, 477.e1. PubMed ID: 19647862
[TBL] [Abstract][Full Text] [Related]
16. Allergen-specific sensitization in asthma and allergic diseases in children: the study on farmers' and non-farmers' children.
Remes ST; Koskela HO; Iivanainen K; Pekkanen J
Clin Exp Allergy; 2005 Feb; 35(2):160-6. PubMed ID: 15725186
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebo-controlled study.
Mirone C; Albert F; Tosi A; Mocchetti F; Mosca S; Giorgino M; Pecora S; Parmiani S; Ortolani C
Clin Exp Allergy; 2004 Sep; 34(9):1408-14. PubMed ID: 15347374
[TBL] [Abstract][Full Text] [Related]
18. [Fifty percent of pollinosis patients sensitive to birch pollen demonstrate bronchoconstriction during bronchial provocation test with the allergen].
Swiebocka E; Siergiejko Z; Siergiejko G; Leoniuk A; Hofman J
Pol Merkur Lekarski; 2008 Jun; 24(144):492-4. PubMed ID: 18702328
[TBL] [Abstract][Full Text] [Related]
19. Ole e 2 and Ole e 10: new clinical aspects and genetic restrictions in olive pollen allergy.
Quiralte J; Llanes E; Barral P; Arias de Saavedra JM; Sáenz de San Pedro B; Villalba M; Florido JF; Rodríguez R; Lahoz C; Cárdaba B
Allergy; 2005 Mar; 60(3):360-5. PubMed ID: 15679723
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
